MiR-124-3p, which reduces in AD, inhibits the translation of CAPN1 mRNA, prevents the conversion of p35 to p25 and the subsequent formation of the p25/CDK5 complex, and reduces abnormal tau phosphorylation (Zhou et al., 2019). Here, MAPT is linked to Alzheimer disease.